Keyword: Handa Pharmaceuticals
News
30.03.2012
- A U.S. court on Thursday ruled that the formulation patent for AstraZeneca's big-selling anti-psychotic drug Seroquel XR was valid and had been infringed by Mylan and other...
News
30.09.2011
- AstraZeneca announced that it has entered into a settlement agreement in its U.S. Seroquel Xr patent infringement litigation against Handa Pharmaceuticals regarding Handa's...